Ke Xiang Zhou
Director/Board Member at BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yue Lei Shen | M | - |
Eucure Beijing Biopharma Co Ltd
| 15 years |
| Xin Yi Xu | F | 47 |
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 years |
| Jian Ni | M | - |
Eucure Beijing Biopharma Co Ltd
| 4 years |
| Hai Jian Zhu | M | 59 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 years |
| Feng Mao Hua | M | 56 | 3 years | |
| Yi Liang Wei | M | 53 |
Eucure Beijing Biopharma Co Ltd
| 6 years |
| Zhi Hong Li | M | - |
Eucure Beijing Biopharma Co Ltd
| 5 years |
| Sabrina Wang | F | - |
Eucure Beijing Biopharma Co Ltd
| 5 years |
| Chao She Guo | M | - | 11 years | |
| Chang Yuan Yu | M | - | 4 years | |
| Shang Ying Ge | F | 37 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 years |
| Feng Tu | M | 50 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 years |
| San Ming Li | M | 67 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 3 years |
| Ying Ye | M | 60 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 12 years |
| Yan Li | F | - |
Eucure Beijing Biopharma Co Ltd
| 4 years |
| Chao Lin Chen | M | 51 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Yuan Qing Luo | M | 56 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Xiao Yan Liang | F | 58 | 4 years | |
| Jia Wei Yao | M | 41 | 12 years | |
| Hai Chao Zhang | M | - |
Eucure Beijing Biopharma Co Ltd
| 2 years |
| Yun Xia Yang | F | 51 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Wai Ching Au | F | - | - | |
| Shuang Wen Zhang | M | 53 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Lei Di Zhang | F | 43 | 2 years | |
| Yuan Tao Song | M | 39 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 years |
| Hua Yi | M | 50 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Ning Yao Lin | M | 53 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 years |
| Jing Rong | M | 42 |
Cmbi Capital Management Shenzhen Co. Ltd.
| - |
| Chun Li Sun | F | - | - | |
| Liu Bin | M | - | 4 years | |
| Yi Yang | M | - | 8 years | |
| Yong Liang Wang | M | 59 | - | |
| Yan Zhu | F | 60 | 13 years | |
| Lei Di Zhang | F | 44 | 2 years | |
| Lin Hui Cai | F | 38 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yu Wang | M | 57 |
Peking University Health Science Center
| 7 years |
| Hui Ou Yang | M | 52 |
Peking University Health Science Center
| 7 years |
| Zhao Long Gong | M | 60 |
Peking University Health Science Center
| 1 years |
| De Min Zhou | M | 58 |
Peking University Health Science Center
| 8 years |
| Yun Hui Yu | M | 62 |
Southern Medical University
| 3 years |
| Zhi Qian Zhang | M | 57 |
Peking University Health Science Center
| 1 years |
| Xiao Yang Fu | M | 49 |
Peking University Health Science Center
| 4 years |
| Xiao Lin Cheng | M | 61 |
Peking University Health Science Center
| 3 years |
| Li Yan | M | 57 |
Peking University Health Science Center
| 4 years |
| JC Xu | M | 60 |
Peking University Health Science Center
| 3 years |
| Jin Jin Liang | M | 55 |
Peking University Health Science Center
| 4 years |
| Jian Zhong Liu | M | 59 |
Peking University Health Science Center
| 4 years |
| Yu Zhang | M | 52 |
Peking University Health Science Center
| 4 years |
| Zheng Cheng | M | 60 |
Southern Medical University
| 4 years |
| Guoxin Shan | M | 62 |
Southern Medical University
| 4 years |
| Hai Yan | M | 57 |
Peking University Health Science Center
| 3 years |
| Cheng Han Wu | M | 66 |
Southern Medical University
| 4 years |
| Lu Wen Shi | M | 60 |
Peking University Health Science Center
| 4 years |
| Ze Chang Xu | M | 62 |
Southern Medical University
| 4 years |
| Ji Min Gao | M | 60 |
Southern Medical University
| 4 years |
| Meng Jun Liu | M | 58 |
Peking University Health Science Center
| 3 years |
| Jing Wang | M | 66 |
Southern Medical University
| 4 years |
| Tong Li | M | 55 |
Peking University Health Science Center
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ke Xiang Zhou
- Personal Network